Sign up
Log in
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Share
Listen to the news

Gainers

  • Reshape Lifesciences (NASDAQ:RSLS) shares rose 93.8% to $0.66 during Thursday's pre-market session. The company's market cap stands at $2.1 million.
  • Sharps Technology (NASDAQ:STSS) shares rose 79.99% to $0.03.
  • Pasithea Therapeutics (NASDAQ:KTTA) stock rose 31.19% to $1.43. The company's market cap stands at $3.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 26.73% to $2.37. The company's market cap stands at $3.3 million.
  • Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 17.54% to $1.31. The company's market cap stands at $7.4 million.
  • Keros Therapeutics (NASDAQ:KROS) shares moved upwards by 17.03% to $12.09. The market value of their outstanding shares is at $490.3 million.

Losers

  • Venus Concept (NASDAQ:VERO) shares decreased by 50.4% to $4.43 during Thursday's pre-market session. The market value of their outstanding shares is at $2.9 million.
  • Lucid Diagnostics (NASDAQ:LUCD) stock declined by 26.67% to $1.21. The market value of their outstanding shares is at $109.8 million.
  • Varex Imaging (NASDAQ:VREX) shares decreased by 18.07% to $7.12. The company's market cap stands at $293.5 million.
  • Upstream Bio (NASDAQ:UPB) stock declined by 15.78% to $5.5. The company's market cap stands at $295.0 million.
  • Innovative Eyewear (NASDAQ:LUCY) stock declined by 15.11% to $2.08. The company's market cap stands at $5.1 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) shares declined by 14.18% to $4.36. The company's market cap stands at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.